Tenaya Therapeutics Inc
NASDAQ:TNYA 3:59:51 PM EDT
Earnings Announcements
Tenaya Therapeutics Reports First Quarter 2022 Results
Published: 05/11/2022 21:57 GMT
Tenaya Therapeutics Inc (TNYA) - Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.75.
Qtrly Net Loss per Share, Basic and Diluted $0.75.
Tenaya Therapeutics - Expects Current Cash, Cash Equivalents, Investments in Marketable Securities Sufficient to Fund Operating Plan Into H2 2023.
Q1 Earnings per Share View $-0.65 -- Refinitiv Ibes Data (analyst estimates).
Q1 Loss per Share $0.75.
Qtrly Net Loss per Share, Basic and Diluted $0.75.
Tenaya Therapeutics - Expects Current Cash, Cash Equivalents, Investments in Marketable Securities Sufficient to Fund Operating Plan Into H2 2023.
Q1 Earnings per Share View $-0.65 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.78
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.78
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84
More details on our Analysts Page.